休克包括研究新的治療方法，如免疫調(diào)節(jié)、基因治療、營(yíng)養(yǎng)和其他。目前還沒(méi)有一本包含病因、細(xì)胞和分子機(jī)制以及以綜合和連貫的方式治療休克的治療方法的雜志，但仍保持對(duì)休克病理學(xué)的明確關(guān)注。該雜志將滿足研究人員目前和未來(lái)的需求，他們參與了對(duì)休克、創(chuàng)傷、敗血癥、內(nèi)毒素血癥、缺血/再灌注、炎癥和其他相關(guān)病理生理狀態(tài)的復(fù)雜基礎(chǔ)和臨床研究。

Shock includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. There is no single journal, which encompasses the etiology, cellular and molecular mechanisms, and therapeutic approaches to the treatment of shock in a comprehensive and coherent manner, while still maintaining a clear focus on the pathobiology of shock. The journal is poised to meet the present and future needs of investigators involved in sophisticated basic and clinical studies of shock, trauma, sepsis, endotoxemia, ischemia/reperfusion, inflammation, and other related pathophysiologic states.